In colorectal cancer, breast cancer and hepatocellular cancer, the activation of the Wnt/β-catenin pathway leads to a worse overall survival as high levels of CTNNB1 promotes metastasis and epithelial-mesenchymal transition (EMT) (57). Here, CTNNB1 is linked to breast cancer.